Article Details

A startup raises $336M to make a better antibody drug for COVID-19

Retrieved on: 2021-04-19 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

A startup raises $336M to make a better antibody drug for COVID-19. View article details on hiswai:

Excerpt

Adagio is "continuously evaluating all options" and focused on ADG20, CEO Tillman Gerngross told BioPharma Dive. Multiple antibody drugs are ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up